Frontier Scientific Solutions got its start in the pharmaceutical logistics space after CEO Steve Uebele discovered a problem that needed solving.

“I started Frontier Scientific Solutions to solve critical gaps I saw in the pharmaceutical supply chain – especially in temperature-controlled logistics, regulatory inefficiencies and fragmented international distribution,” Uebele wrote in an email. “The mission was clear: build a purpose-driven platform that prioritizes quality, compliance and speed to ensure life-saving therapies reach patients without compromise.”

The pharmaceutical supply chain consists of all the processes – such as manufacturing, distributing and dispensing – required to deliver medications to patients. The supply chain is also comprised of multiple stakeholders, including regulatory agencies, wholesalers, health care providers, pharmaceutical manufacturers and patients.

According to Uebele, Frontier Scientific Solutions is a pharmaceutical logistics company that focuses on temperature-controlled storage, handling that is Good Manufacturing Practice (GMP) compliant and global transportation of clinical and commercial products. He noted that the company also provides end-to-end support for life sciences companies and combines infrastructure, regulatory oversight and technology to manage complex supply chains with precision and reliability.

Uebele additionally emphasized that the company goes a step further than merely moving products; he said that it protects the products’ integrity across the full supply chain and listed several things he believes set Frontier Scientific Solutions apart. Among these are specialized infrastructure, regulatory expertise, direct tarmac access for time-sensitive shipments, full-use facilities that are Foreign Trade Zone (FTZ)-bonded, a scalable workforce and technology platform and a customs border patrol and TSA screening center within the facility.

An FTZ zone doesn’t have to follow normal customs regulations since it’s located within a geographical area that isn’t considered U.S. customs territory. This designated area allows companies to minimize or eliminate duties and excise taxes on imported goods. However, FTZ-bonded facilities differ from customs-bonded facilities in that customs-bonded facilities are regulated by customs authorities and go through customs procedures; they’re considered part of U.S. customs territory.

And with customs-bonded facilities, goods can be stored, manipulated or manufactured without duties for up to five years. Another difference between the two types of facilities, though, is that companies can store goods in an FTZ-bonded warehouse for an unlimited period. With customs-bonded warehouses, however, imported goods have a five-year storage limit.

When referencing the company’s specialized infrastructure, Uebele mentioned that it is building a 530,000-square-foot warehouse in Wilmington and a 70,000-square-foot facility at Shannon Airport in Ireland.

And as for milestones, Frontier Scientific Solutions has accomplished a great deal since its inception. This includes designing two major facilities in North Carolina and Ireland, building a specialized logistics and regulatory team, partnering with key stakeholders across the pharmaceutical, biotechnology and government spaces and investing in integrated quality systems and cold chain infrastructure, according to Uebele.

He said he’s most proud of having assembled a team with deep industry experience. Another thing he expressed satisfaction with was in becoming a trusted partner to companies and agencies who rely on the company’s ability to deliver therapies safely and on time.

Many big things are on the horizon for Frontier Scientific Solutions this year. Its slate for 2025 includes launching facilities in both Wilmington and Shannon, Ireland, hiring more than 100 specialized employees, rolling out advanced tech platforms and expanding internationally into markets in Europe, the Asia-Pacific, Latin America, Africa and the Middle East, Uebele said.

“Our long-term goal,” he said, “is to become the global standard for compliant, temperature-controlled pharmaceutical logistics.”

Meet the 2025 CEA Winners